跳至主要内容
临床试验/CTRI/2014/03/004446
CTRI/2014/03/004446
招募中
未知

Tumor specific whole genome expression analysis to determine patient specific chemotherapies and/or adjuvant therapies

Mazumdar Shaw Medical Center0 个研究点目标入组 14 人开始时间: 待定最近更新:

概览

阶段
未知
状态
招募中
发起方
Mazumdar Shaw Medical Center
入组人数
14

概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Newly Diagnosed and recurrent Leukemia
  • \- Willing to provide informed consent

排除标准

  • \-Patients with the history of heart diseases. e.g., NYHA Functional Class III or IV heart failure, Myocardial Infarction within 6 months , ventricular tachyarrhythmias requiringongoing treatment, or unstable angina, or heart rhythm disorder
  • \-Patients with the history of psychological problems that would precludeparticipation in the study(like confusion, hallucination, loss of balance, change in the way you walk or talk, decreased).
  • \-Patients for whom, in the opinion of the investigator, their general status would not permit the administration of chemotherapy
  • \-Inability of the patient or Legally Acceptable Representative to give the informed consent.
  • \-Patients who are participating in another clinical trial currently.

研究者

发起方
Mazumdar Shaw Medical Center

相似试验